Key result
Lower TIR is linked to sudomotor dysfunction in type 1 diabetes.
Why the study?
Is time in range (TIR) associated with sudomotor dysfunction in individuals with type 1 diabetes mellitus?
Is time in range (TIR) associated with sudomotor dysfunction in individuals with type 1 diabetes mellitus?
Time in range is inversely associated with sudomotor dysfunction in type 1 diabetes, suggesting it is a useful metric for predicting early microvascular complications independent of HbA1c.
Answers are grounded in this paper and cite their sources.
TIR may aid early sudomotor dysfunction detection in T1DM; this cross-sectional link leaves open prospective validation before clinical adoption.
INTRODUCTION: Time in range (TIR), a novel metric to evaluate glycemic control, is relevant to predict microvascular complications of diabetes. Sudomotor dysfunction is among the earliest findings detectable in diabetic peripheral neuropathy (DPN). This study aimed to evaluate the relationship between TIR obtained from continuous glucose monitoring (CGM) and sudomotor function evaluated by SUDOSCAN in subjects with type 1 diabetes mellitus (T1DM). MATERIALS AND METHODS: We enrolled 90 individuals with T1DM. All of them underwent SUDOSCAN and 14-day CGM. SUDOSCAN measured feet electrochemical skin conductance (FESC), and sudomotor dysfunction was defined as average FESC<70μS. Logistic regressions were applied to examine the independent association between TIR and glycated hemoglobin (HbA1c) and sudomotor function. RESULTS: The overall prevalence of sudomotor dysfunction was 65.6%. Patients with sudomotor dysfunction showed a decreased level of TIR (53.3±17.4% vs 64.4±12.7%, P<.05). No significant differences in HbA1c were observed between the groups with and without sudomotor dysfunction (median 8.1% [65mmol/mol] vs 7.6% [60mmol/mol]; P=.094). Correlation analysis showed that the relationship between TIR and FESC was stronger than between HbA1c and FESC. Finally, logistic regression revealed that TIR was inversely associated with the risk of sudomotor dysfunction detected by SUDOSCAN (P<.05). CONCLUSIONS: TIR is a glycemic control target inversely associated with sudomotor dysfunction assessed by SUDOSCAN in T1DM regardless of HbA1c.
No takes yet. Share an insight, caveat, or question.
Quintal-Medina et al. (2026) studied this question. Time in range was inversely associated with sudomotor dysfunction in type 1 diabetes, with lower TIR observed in patients with dysfunction compared to those without.
Synapse has enriched 10 related papers. Consider them for comparative context: